Semaglutide in the treatment of peripheral arterial disease
TW202633904APending Publication Date: 2026-08-16NOVO NORDISK AS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114142778
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-03-28
- Filing Date
- 2025-11-04
- Publication Date
- 2026-08-16
Abstract
Disclosed herein is a further medical use of semaglutide, namely semaglutide in the treatment of a human subject with peripheral arterial disease. Semaglutide is shown to have a positive impact on symptoms of intermittent claudication, and therefore the functional limb capacity, of patients with type
Need to check novelty before this filing date? Find Prior Art